Abstract:Objectives BackgroundSCN5A is encoding human sodium channel protein Nav1.5. Mutations on SCN5A have been found to induce multiple fatal arrhythmia syndromes, such as Long QT syndrome (LQTS), atrioventricular block (AVB) and Brugada syndrome. This study aimed to explore the pathogenic spectrum, characteristics and therapeutic outcomes of the syndromes caused by mutations on SCN5A.MethodsOne LQT3 kindred and an AVB kindred from the Chinese National Channelopathy Registry Study were investigated. Blood samples and clinical data were obtained under written consents. Mutational screening of SCN5A gene was performed via PCR and direct DNA sequence analysis. LQTS or AVB phenotype and therapeutic outcomes were evaluated for all probands and family members. Genotype-phenotype evaluation was also performed for family members. Mutational analyses were based on NCBI standardised mRNA sequence (SCN5A: NM_198056.2).ResultsThe LQTS proband was a 1-year-old girl (test-tube baby). She had her first syncope at 9-month-old in night sleep. Afterwards several episodes of syncope occurred, often accompanied by Torsades de Pointes (TdP) and ventricular fibrillation. ECG showed a maximum QTc of 690ms, while no abnormality was found on ECG of her parents. Gene screening of SCN5A identified a novel mutation F1473S (4418 T>C) on the proband, but this mutation was not detected on the parents, indicating a de novo mutation. Medication with propranolol (2.5 mg/kg/d) alone did not improve the symptoms. Additional use of mexiletine (12.5 mg/kg/d) showed some improvement, but syncopes still occurred now and then. Then the dosage was adjusted to propranolol (2.5 mg/kg/d) and mexilatine (15 mg/kg/d). The girl died at 23-month-old, though the external defibrillator was used at home. The AVB proband is a 57-year-old male. He showed symptoms of bradycardia, short of breath and even inability to lie down. ECG indicated complete right bundle branch block (RBBB) and left anterior fascicular block. He has received pacemaker implantation in March of 2011 and no symptoms occurred since then. A novel mutation F919L (2757C>A) on SCN5A was found. No AVB related symptoms were found on his family members, except for RBBB showed in the ECG of his son and brother. Gene screening detected the same mutation in both persons. To note, the proband9s father had sudden death at age of 57, but no DNA sample is available to determine his genotype.ConclusionsThe present study revealed two novel mutations, F1473S and F919L on SCN5A, which have not been reported. The two novel mutations induced distinct but equally lethal arrhythmia syndromes, LQTS and AVB, respectively. In consider of the reports in western countries of relatively severe LQTS-causing mutation F1473C (4418 T>G) on SCN5A, we may also conclude that the site SCN5A1473 is a mutational “hot spot”, which characterises an early onset and severe phenotype of LQT3.

Mechanisms by Which SCN5A Mutation N1325S Causes Cardiac Arrhythmias and Sudden Death in Vivo.

Characterization of the cardiac sodium channel SCN5A mutation, N1325S, in single murine ventricular myocytes

LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice

Α-1-syntrophin Mutation and the Long-QT Syndrome

The Common SCN5A Mutation R1193Q Causes LQTS-type Electrophysiological Alterations of the Cardiac Sodium Channel

NOVEL MUTATIONS ON SCN5A CAUSED FATAL ARRHYTHMIA SYNDROME IN CHINESE

Computational Cardiac Modeling Reveals Mechanisms of Ventricular Arrhythmogenesis in Long QT Syndrome Type 8: CACNA1C R858H Mutation Linked to Ventricular Fibrillation

Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.

Mutations In Cytoplasmic Loops Of The Kcnq1 Channel And The Risk Of Life-Threatening Events Implications For Mutation-Specific Response To Beta-Blocker Therapy In Type 1 Long-Qt Syndrome

Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome

Optical mapping of ventricular arrhythmias in LQTS mice with SCN5A mutation N1325S.

Digenic Heterozygous Mutations of KCNH2 and SCN5A Induced Young and Early‐onset Long QT Syndrome and Sinoatrial Node Dysfunction

Cardiac-specific overexpression of SCN5A gene leads to shorter P wave duration and PR interval in transgenic mice.

A Molecular Mechanism for Adrenergic-Induced Long QT Syndrome.

A Common SCN5A Polymorphism Attenuates a Severe Cardiac Phenotype Caused by a Nonsense SCN5A Mutation in a Chinese Family with an Inherited Cardiac Conduction Defect

[High Incidence of Sudden Cardiac Death in One Family with Type-3 Long QT Syndrome: Molecular Genetics and Electrophysiology Mechanism Analysis].

Pro-Arrhythmogenic Effects of Cacna1c G1911r Mutation in Human Ventricular Tachycardia: Insights from Cardiac Multi-Scale Models

Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.

The cardiac sodium channel mutation delQKP 1507-1509 is associated with the expanding phenotypic spectrum of LQT3, conduction disorder, dilated cardiomyopathy, and high incidence of youth sudden death.

In Silico Investigation of the CACNA1C N2091S Mutation in Timothy Syndrome.

In Silico Investigation of CACNA2D1 S755T Mutation Associated with Short QT Syndrome